TrialInternational journal of clinical practice2012

Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial.

R R Henry et al.PubMed ↗Publisher ↗

No numbers read from the abstract.